Literature DB >> 34347558

Atopic asthma as a potentially significant but unrecognized risk factor for Kawasaki disease in children.

Bong Seok Choi1,2, Editt Nikoyan Taslakian3, Chung-Il Wi2, Youn Ho Shin4, Hee Yun Seol2,5, Euijung Ryu6, Thomas G Boyce7, Jonathan N Johnson8, Katherine S King6, Jung Hyun Kwon2,9, Young J Juhn2,8.   

Abstract

OBJECTIVES: Childhood asthma is known to be associated with risks of both respiratory and non-respiratory infections. Little is known about the relationship between asthma and the risk of Kawasaki disease (KD). We assessed associations of asthma status and asthma phenotype (e.g. atopic asthma) with KD.
METHODS: We performed a population-based retrospective case-control study, using KD cases between January 1, 1979, and December 31, 2016, and two matched controls per case. KD cases were defined by the American Heart Association diagnostic criteria. Asthma status prior to KD (or control) index dates was ascertained by the two asthma criteria, Predetermined Asthma Criteria (PAC) and Asthma Predictive Index (API, a surrogate phenotype of atopic asthma). We assessed whether 4 phenotypes (both PAC + and API+; PAC + only; API + only, and non-asthmatics) were associated with KD.
RESULTS: There were 124 KD cases during the study period. The group having both PAC + and API + was significantly associated with the increased odds of KD, compared to non-asthmatics (odds ratio [OR] 4.3; 95% CI: 1.3 - 14.3). While asthma defined by PAC was not associated with KD, asthma defined by PAC positive with eosinophilia (≥4%) was significantly associated with the increased odds of KD (OR: 6.7; 95% CI: 1.6 - 28.6) compared to non-asthmatics. Asthma status defined by API was associated with KD (OR = 4.7; 95% CI: 1.4-15.1).
CONCLUSIONS: Atopic asthma may be associated with increased odds of KD. Further prospective studies are needed to determine biological mechanisms underlying the association between atopic asthma and increased odds of KD.

Entities:  

Keywords:  Epidemiology; pediatrics; phenotypes

Mesh:

Year:  2021        PMID: 34347558      PMCID: PMC8885770          DOI: 10.1080/02770903.2021.1963765

Source DB:  PubMed          Journal:  J Asthma        ISSN: 0277-0903


  34 in total

1.  A clinical index to define risk of asthma in young children with recurrent wheezing.

Authors:  J A Castro-Rodríguez; C J Holberg; A L Wright; F D Martinez
Journal:  Am J Respir Crit Care Med       Date:  2000-10       Impact factor: 21.405

2.  Atopic Predilection among Kawasaki Disease Patients: A Cross-Sectional Study of 1,187,757 Teenagers.

Authors:  Ayal Hassidim; Ilan Merdler; Odelia Chorin; Rona Merdler-Rabinowicz; Ilan Dallal; Maxim Perlman; Ehud Chorin
Journal:  Int Arch Allergy Immunol       Date:  2016-07-21       Impact factor: 2.749

3.  Heterogeneity of asthma and the risk of celiac disease in children.

Authors:  Bhavisha Patel; Chung-Il Wi; M Earth Hasassri; Rohit Divekar; Imad Absah; Eyad Almallouhi; Euijung Ryu; Katherine King; Young J Juhn
Journal:  Allergy Asthma Proc       Date:  2018-01-01       Impact factor: 2.587

Review 4.  Risk Factors for Herpes Zoster: A Systematic Review and Meta-analysis.

Authors:  Kosuke Kawai; Barbara P Yawn
Journal:  Mayo Clin Proc       Date:  2017-12       Impact factor: 7.616

Review 5.  Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association.

Authors:  Brian W McCrindle; Anne H Rowley; Jane W Newburger; Jane C Burns; Anne F Bolger; Michael Gewitz; Annette L Baker; Mary Anne Jackson; Masato Takahashi; Pinak B Shah; Tohru Kobayashi; Mei-Hwan Wu; Tsutomu T Saji; Elfriede Pahl
Journal:  Circulation       Date:  2017-03-29       Impact factor: 29.690

6.  A polymorphism in plasma platelet-activating factor acetylhydrolase is involved in resistance to immunoglobulin treatment in Kawasaki disease.

Authors:  Takaomi Minami; Hiroyuki Suzuki; Takashi Takeuchi; Shigeru Uemura; Junko Sugatani; Norishige Yoshikawa
Journal:  J Pediatr       Date:  2005-07       Impact factor: 4.406

7.  Asthma as a risk factor for zoster in adults: A population-based case-control study.

Authors:  Hyo Jin Kwon; Duk Won Bang; Eun Na Kim; Chung-Il Wi; Barbara P Yawn; Peter C Wollan; Brian D Lahr; Euijung Ryu; Young J Juhn
Journal:  J Allergy Clin Immunol       Date:  2015-12-28       Impact factor: 10.793

8.  The relationship of eosinophilia to intravenous immunoglobulin treatment failure in Kawasaki disease.

Authors:  Ho-Chang Kuo; Kuender D Yang; Chi-Di Liang; Chin-Nam Bong; Hong-Ren Yu; Lin Wang; Chih-Lu Wang
Journal:  Pediatr Allergy Immunol       Date:  2007-06       Impact factor: 6.377

9.  Atopic diathesis in patients with Kawasaki disease.

Authors:  Chian-Yaw Hwang; Yu-Ya Hwang; Yi-Ju Chen; Chih-Chiang Chen; Ming-Wei Lin; Tzeng-Ji Chen; Ding-Dar Lee; Yun-Ting Chang; Wen-Jeng Wang; Han-Nan Liu
Journal:  J Pediatr       Date:  2013-05-03       Impact factor: 4.406

10.  Gene expression in relation to exhaled nitric oxide identifies novel asthma phenotypes with unique biomolecular pathways.

Authors:  Brian D Modena; John R Tedrow; Jadranka Milosevic; Eugene R Bleecker; Deborah A Meyers; Wei Wu; Ziv Bar-Joseph; Serpil C Erzurum; Benjamin M Gaston; William W Busse; Nizar N Jarjour; Naftali Kaminski; Sally E Wenzel
Journal:  Am J Respir Crit Care Med       Date:  2014-12-15       Impact factor: 30.528

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.